Nova MSC bags RM7.13mil contract for AI-driven National DR screening programme in Brunei

PETALING JAYA: Nova MSC Bhd, via its subsidiary EyRIS Pte Ltd, has secured a contract worth RM7.13mil from JPMCnova Sdn Bhd to Roll out of the National Diabetic Retinopathy (DR) Screening Program in Brunei Darussalam.

Nova, a provider of industry-focused application software and services for the healthcare sector, said in a statement Brunei is one of the earliest countries in the world to strengthen its public health system by integrating a deep learning system into their national DR screening program. It said the five-year project is set to commence in October 2024 and will use EyRIS’ advanced artificial intelligence platforms across hospitals and healthcare centres in the country.